Cargando…
Not All Vaccines are Cost-beneficial in Developing Countries
Autores principales: | Garg, Ashish, Golwala, Zainab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703221/ https://www.ncbi.nlm.nih.gov/pubmed/23853442 http://dx.doi.org/10.4103/0974-777X.112291 |
Ejemplares similares
-
Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries
por: Velpandian, T, et al.
Publicado: (2007) -
Introducing HPV Vaccine in Developing Countries - Addressing the Challenge
por: Mukhopadhyay, Prianka, et al.
Publicado: (2009) -
Hepatitis A vaccination in developing countries: Is Syria next?
por: Habboub, Ghaith, et al.
Publicado: (2012) -
Intern year in a developing country amidst COVID-19
por: Shrigiriwar, Apurva, et al.
Publicado: (2020) -
All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)